SCHEMBL6102480

SCHEMBL6102480

CCc1ccc(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCC1CCOCC1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 6/20 0.59
BRD4 O60885 1/20 0.45
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
WNT3 P56703 2/20 0.40
MAPK1 P28482 1/20 0.39
CNR2 P34972 2/20 0.38
NPC1 O15118 1/20 0.38
GBA1 P04062 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM1A O60341 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617958 0.93 SFRP1 (0.51) SFRP1BRD4ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4618967 0.88 SFRP1 (0.61) SFRP1BRD4ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4619001 0.84 SFRP1 (0.41) SFRP1BRD4ALDH1A1SMN1; SMN2PIK3CD
SCHEMBL4618493 0.83 SFRP1 (0.47) SFRP1BRD4ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL6101508 0.82 SFRP1 (0.52) SFRP1ALDH1A1SMN1; SMN2L3MBTL1WNT3
SCHEMBL4616759 0.82 GBA1 (0.48) SFRP1ALDH1A1SMN1; SMN2L3MBTL1CNR2
SCHEMBL17205770 0.81 GBA1 (0.55) BRD4ALDH1A1SMN1; SMN2MAPK1NPC1
SCHEMBL4616479 0.81 SFRP1 (0.74) SFRP1ALDH1A1SMN1; SMN2L3MBTL1MAPK1
SCHEMBL4617455 0.81 SFRP1 (0.46) SFRP1BRD4ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4617904 0.80 CNR2 (0.45) SFRP1CNR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885BRD4 2225/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.